Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emiliano Antiga

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|June 28, 2024
It is time to reconsider antibodies against integrin β4 in mucous membrane pemphigoid: Comment on 'Native collagen XVII complex ELISA: An approach for diagnosis and monitoring of anti-integrin β4 mucous membrane pemphigoid'Roberto Maglie, Emiliano Antiga
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|December 17, 2016
Rowell's Syndrome or subacute cutaneous lupus erythematosus?Emiliano Antiga, Marzia Caproni
International Journal of Dermatology|March 1, 2017
Multiple mucosal ulcerations caused by idelalisibMassimiliano Galeone, Emiliano Antiga
International Journal of Dermatology|June 10, 2020
Nivolumab-induced erosive pustular dermatosis of the scalpRoberto Maglie, Emiliano Antiga
Clinical, Cosmetic and Investigational Dermatology|May 23, 2015
The diagnosis and treatment of dermatitis herpetiformisEmiliano Antiga, Marzia Caproni
The British Journal of Dermatology|May 16, 2026
Patient phenotyping to guide therapeutic strategies in bullous pemphigoid: towards personalized medicine in autoimmune bullous diseasesRoberto Maglie, Emiliano Antiga
Cellular Immunology|July 13, 2010
Immunosuppressive therapy may affect the number of circulating regulatory cells in systemic sclerosis: Pay attention to the patient selection criteriaEmiliano Antiga, Paolo Fabbri, Marzia Caproni
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 2011
Comment on "Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology"Emiliano Antiga, Marzia Caproni, Paolo Fabbri
The Journal of Investigative Dermatology|December 11, 2020
T-Cell Response in Dermatitis Herpetiformis: May Epidermal Transglutaminase Play a Role in Predicting Clinical Relapse?Emiliano Antiga, Roberto Maglie, Paolo Fabbri
Journal of the American Academy of Dermatology|January 9, 2018
Comment on "Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis"Roberto Maglie, Emiliano Antiga, Marzia Caproni
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Journal of the European Academy of Dermatology and Venereology : JEADV|June 28, 2024
It is time to reconsider antibodies against integrin β4 in mucous membrane pemphigoid: Comment on 'Native collagen XVII complex ELISA: An approach for diagnosis and monitoring of anti-integrin β4 mucous membrane pemphigoid'Roberto Maglie, Emiliano Antiga
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|December 17, 2016
Rowell's Syndrome or subacute cutaneous lupus erythematosus?Emiliano Antiga, Marzia Caproni
International Journal of Dermatology|March 1, 2017
Multiple mucosal ulcerations caused by idelalisibMassimiliano Galeone, Emiliano Antiga
International Journal of Dermatology|June 10, 2020
Nivolumab-induced erosive pustular dermatosis of the scalpRoberto Maglie, Emiliano Antiga
Clinical, Cosmetic and Investigational Dermatology|May 23, 2015
The diagnosis and treatment of dermatitis herpetiformisEmiliano Antiga, Marzia Caproni
The British Journal of Dermatology|May 16, 2026
Patient phenotyping to guide therapeutic strategies in bullous pemphigoid: towards personalized medicine in autoimmune bullous diseasesRoberto Maglie, Emiliano Antiga
Cellular Immunology|July 13, 2010
Immunosuppressive therapy may affect the number of circulating regulatory cells in systemic sclerosis: Pay attention to the patient selection criteriaEmiliano Antiga, Paolo Fabbri, Marzia Caproni
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 2011
Comment on "Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology"Emiliano Antiga, Marzia Caproni, Paolo Fabbri
The Journal of Investigative Dermatology|December 11, 2020
T-Cell Response in Dermatitis Herpetiformis: May Epidermal Transglutaminase Play a Role in Predicting Clinical Relapse?Emiliano Antiga, Roberto Maglie, Paolo Fabbri
Journal of the American Academy of Dermatology|January 9, 2018
Comment on "Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis"Roberto Maglie, Emiliano Antiga, Marzia Caproni
Pageof 13